Literature DB >> 24434731

Letter to the editor.

Yigal Paul Goldberg1, Charles J Cohen, Rostam Namdari, Nicola Price, Jay A Cadieux, Clint Young, Robin Sherrington, Simon Neil Pimstone.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24434731     DOI： 10.1016/j.pain.2014.01.003

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  3 in total

Review 1.  Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7.

Authors:  John V Mulcahy; Hassan Pajouhesh; Jacob T Beckley; Anton Delwig; J Du Bois; John C Hunter
Journal:  J Med Chem       Date:  2019-05-07       Impact factor: 7.446

Review 2.  Inhibition of NaV1.7: the possibility of ideal analgesics.

Authors:  Yutaka Kitano; Tsuyoshi Shinozuka
Journal:  RSC Med Chem       Date:  2022-08-01

3.  Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype.

Authors:  Nicola Price; Rostam Namdari; Judith Neville; Katie J W Proctor; Samer Kaber; Jeffery Vest; Michael Fetell; Richard Malamut; Robin P Sherrington; Simon N Pimstone; Yigal P Goldberg
Journal:  Clin J Pain       Date:  2017-04       Impact factor: 3.442
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.